Ethinylestradiol 30μg/drospirenone 3mg (Yasmin® 1, petibelle®)[EE/DRSP] is a combined
contraceptive pill (CC) for the prevention of pregnancy in women of reproductive age …

Drospirenone is a novel synthetic progestogen with a pharmacological profile similar to that
of natural progesterone. It has been developed in combination with ethinylestradiol for use …

Drospirenone 3 mg/ethinyl estradiol 20 microg (24/4) is a new unique oral contraceptive
formulation that combines in a novel dosing regimen the lowest dosage of ethinyl estradiol …

Considerable advances have been made in the field of combined oral contraceptives since
their introduction 50 years ago. This ongoing evolution has been focused on reducing the …

Drospirenone 3mg with ethinylestradiol 20µg (Yaz®) is a low-dose combined oral
contraceptive (COC) administered in a regimen of 24 days of active tablets followed by a …

Drospirenone (ZK 30595; 6β, 7β, 15β, 16β-dimethylen-3-oxo-17α-pregn-4-ene-21, 17-carbo-
lactone) is a novel progestogen under clinical development. Potential applications include …

OBJECTIVE: To review the scientific publications concerning the clinical use of
drospirenone (DRSP) as the progestin in combined oral contraceptives (OCs), and as …

Objective To assess the contraceptive reliability, cycle control and tolerance of a new
monophasic oral contraceptive (Yasmin®) containing 30 μg ethinylestradiol and 3 mg …

In the second half of a normal menstrual cycle, progesterone levels rise. Progesterone binds
to its specific receptor, but also to the mineralocorticoid receptor; thus progesterone acts as a …

Drospirenone is a novel progestin available in combined oral contraceptives and
menopausal hormonal therapy. Similar to its parent compound spirolactone, an analog of …